Dr. Charles Oscar Kolthoff

DDS | Dentist



  
  2384 Monroe Ave, Rochester
  New York, 14618-3032

  585-442-1710    Maps & Directions
Dr. Charles Oscar Kolthoff is a Rochester, New York based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 2384 Monroe Ave, Rochester. Patients can reach him at 585-442-1710.
Dr. Charles Oscar Kolthoff is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Charles Oscar Kolthoff speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Charles Oscar Kolthoff
Specialization: Dentist
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:2384 Monroe Ave, Rochester,
New York, 14618-3032
Phone:585-442-1710
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 1052629235
Enrollment ID: I20151008000493
NPI Number: 1952326308
NPI Enumeration Date: 13 Jul, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 2384 Monroe Ave,
Rochester, New York
Zip: 14618-3032
Phone Number: 585-442-1710
Patients can reach Dr. Charles Oscar Kolthoff at 2384 Monroe Ave, Rochester, New York or can call to book an appointment on 585-442-1710. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: